US Patent Issued to Yeda Research and Development on Dec. 30 for "Genetically modified anti-third party central memory T cells and use of same in immunotherapy" (Israeli, American Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,307, issued on Dec. 30, was assigned to Yeda Research and Development Co. Ltd. (Rehovot, Israel).

"Genetically modified anti-third party central memory T cells and use of same in immunotherapy" was invented by Yair Reisner (Houston), Noga Or-Geva (Rehovot, Israel), Eran Ophir (Rehovot, Israel), Yaki Eidelstein (Rehovot, Israel) and Rotem Gidron Budovsky (Rehovot, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "An isolated cell having a central memory T-lymphocyte (Tcm) phenotype, the cell being tolerance-inducing cell and capable of homing to the lymph nodes following transplantation, the cell being transduced to express a cell surface recepto...